Teladoc Health earnings release, July 29, 2026

Teladoc Health, Inc. (TDOC) · Form 8-K, Item 2.02 · Filed · SEC filing

Teladoc Health Reports Second Quarter 2026 Results

NEW YORK, July 29, 2026 — Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2026 (“Second Quarter 2026”). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2025 (“Second Quarter 2025”).

Highlights

• Second Quarter 2026 revenue of $606.9 million, down 4% year-over-year

• Second Quarter 2026 net loss of $38.9 million, or $0.21 per share

• Second Quarter 2026 adjusted EBITDA of $65.7 million, down 5% year-over-year

• Integrated Care segment revenue of $394.3 million, up 1% year-over-year, and adjusted EBITDA margin of 16.5%

• BetterHelp segment revenue of $212.6 million, down 12% year-over-year, and adjusted EBITDA margin of 0.2%

“We continue to make progress on the priorities we believe are most important to the long-term success of Teladoc Health. Our second-quarter results were within our guidance ranges on a consolidated basis and reflected distinct dynamics across our two segments,” said Chuck Divita, Chief Executive Officer of Teladoc Health. “We delivered solid Integrated Care segment performance, with revenue growth and adjusted EBITDA margin above the midpoint of our guidance ranges and continued to advance new innovations designed to strengthen the value we provide to clients and members, including the launch of Teladoc One, our new connected care model for the U.S. market.”

“In the BetterHelp segment, insurance revenue came in near the high end of our expectations. However, pressure on cash pay revenue accelerated further in late May and into June, beyond the assumptions underlying our prior outlook. We saw stronger than anticipated demand for insurance covered services that outpaced available provider capacity, limiting our ability to convert a greater share of that demand into sessions and revenue to offset the cash pay decline. Given strong consumer preference for insurance, we accelerated the nationwide insurance rollout ahead of plan, and we are taking focused actions to further support the scaling of insurance.

We continue to expect 2026 insurance revenue within our previously communicated range, but we have lowered our BetterHelp segment revenue outlook to reflect updated assumptions for cash pay including prioritization of the growing insurance market. We are addressing BetterHelp’s near-term challenges with urgency and discipline and believe these actions will strengthen our ability to meet growing insurance demand and position the segment for more durable performance over time.”

See note (1) in the Notes section that follows.¹

Second Quarter 2026

Revenue decreased 4% to $606.9 million from $631.9 million in Second Quarter 2025. Access fees revenue decreased 9% to $474.2 million while other revenue increased 23% to $132.7 million. U.S. revenue decreased 6% to $487.4 million while International revenue increased 7% to $119.6 million.

Integrated Care segment revenue increased 1% to $394.3 million in Second Quarter 2026 while BetterHelp segment revenue decreased 12% to $212.6 million.

Net loss totaled $38.9 million, or $0.21 per share, for Second Quarter 2026, compared to $32.7 million, or $0.19 per share, for Second Quarter 2025. Results for Second Quarter 2026 included amortization of intangibles of $88.4 million, or $0.49 per share pre-tax, and stock-based compensation expense of $9.3 million, or $0.05 per share pre-tax.

Results for Second Quarter 2025 included amortization of intangibles of $88.7 million, or $0.50 per share pre-tax, and stock-based compensation expense of $22.3 million or $0.13 per share pre-tax. Net loss for Second Quarter 2025 also included restructuring costs related to severance costs and costs associated with office space reductions of $5.7 million, or $0.03 per share pre-tax. These items were partially offset by an acquisition related tax benefit of $9.7 million, or $0.06 per share.

Adjusted EBITDA

Financial statements

Income Statement (In thousands, except per share data, unaudited)

Three Months Ended – June 30, – 2026Three Months Ended – June 30, – 2025ChangeSix Months Ended – June 30, – 2026Six Months Ended – June 30, – 2025Change
(In thousands, except per share data, unaudited)Revenue606,927631,900-4.0%1,220,7721,261,269-3
(In thousands, except per share data, unaudited)Net loss-38,908-32,660-19.0%-102,745-125,67218
(In thousands, except per share data, unaudited)Net loss per share-0.21-0.19-11.0%-0.57-0.7221
(In thousands, except per share data, unaudited)Adjusted EBITDA (1)65,71369,311-5.0%123,882127,404-3

Income Statement

The outlook provided below is based on current market conditions and expectations and what we know today.

Full Year 2026 Outlook Range
For the full year of 2026, we expect:Revenue$2,362 - $2,447 million
For the full year of 2026, we expect:Adjusted EBITDA$271 - $303 million
For the full year of 2026, we expect:Net loss per share($1.00) - ($0.75)
For the full year of 2026, we expect:Free Cash Flow$130 - $170 million
For the full year of 2026, we expect:U.S. Integrated Care Members (2)98.5 - 100.5 million
Integrated CareRevenue growth percentage (year-over-year)0.8% - 2.4%
Integrated CareAdjusted EBITDA margin15.6% - 16.4%
BetterHelpRevenue growth percentage (year-over-year)(19.0%) - (12.7%)
BetterHelpAdjusted EBITDA margin3.0% - 4.6%

Income Statement

For the third quarter of 2026, we expect: — The outlook provided below is based on current market conditions and expectations and what we know today.

For the third quarter of 2026, we expect: – 3Q 2026 Outlook Range
Revenue$569 - $609 million
Adjusted EBITDA$62 - $74 million
Net loss per share($0.30) - ($0.20)
U.S. Integrated Care Members (2)99.0 - 100.5 million
Integrated CareRevenue growth percentage (year-over-year)0.0% - 3.0%
Integrated CareAdjusted EBITDA margin15.7% - 17.2%
BetterHelpRevenue growth percentage (year-over-year)(24.2%) - (12.3%)
BetterHelpAdjusted EBITDA margin0.5% - 2.5%

Income Statement

Three Months Ended June 30, — (In thousands, except share and per share data, unaudited)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Revenue606,927631,9001,220,7721,261,269
Costs and expenses:Cost of revenue (exclusive of depreciation and amortization, which are shown separately below)190,837190,537388,363387,366
Costs and expenses:Advertising and marketing143,397167,547294,924335,732
Costs and expenses:Sales49,39149,951100,66798,644
Costs and expenses:Technology and development62,86168,784130,726138,742
Costs and expenses:General and administrative104,029108,114206,122220,888
Costs and expenses:Goodwill impairment59,138
Costs and expenses:Acquisition, integration, and transformation costs1,6902,6582,7544,846
Costs and expenses:Restructuring costs9045,69212,87910,039
Costs and expenses:Amortization of intangible assets88,44288,664178,268172,968
Costs and expenses:Depreciation of property and equipment2,4684,3384,9297,902
Costs and expenses:Total costs and expenses644,019686,2851,319,6321,436,265
Costs and expenses:Loss from operations-37,092-54,385-98,860-174,996
Costs and expenses:Interest income-6,481-10,064-12,971-22,738
Costs and expenses:Interest expense5,1094,47310,47710,238
Costs and expenses:Other expense (income), net2,191-8,3712,387-10,806
Costs and expenses:Loss before provision for income taxes-37,911-40,423-98,753-151,690
Costs and expenses:Provision for income taxes997-7,7633,992-26,018
Costs and expenses:Net loss-38,908-32,660-102,745-125,672
Costs and expenses:Net loss per share, basic and diluted-0.21-0.19-0.57-0.72
Costs and expenses:Weighted-average shares used to compute basic and diluted net loss per share181,026,004175,917,380180,079,395175,040,625

Income Statement

Three Months Ended June 30, — Compensation expense for stock-based awards was classified as follows (in thousands, unaudited):

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Cost of revenue (exclusive of depreciation and amortization, which are shown separately)1245064711,079
Advertising and marketing4261,3021,2862,805
Sales1,4603,5943,5377,853
Technology and development1,7354,2474,46210,032
General and administrative5,55612,69514,15625,738
Total stock-based compensation expense (3)9,30122,34423,91247,507

Income Statement

Three Months Ended — Revenues (in thousands)

Three Months Ended – June 30, – 2026Three Months Ended – June 30, – 2025ChangeSix Months Ended – June 30, – 2026Six Months Ended – June 30, – 2025Change
Access Fees474,215523,703-9958,8701,049,439-9
Other132,712108,19723261,902211,83024
Total Revenue606,927631,900-41,220,7721,261,269-3
Revenue by GeographyU.S.487,360519,689-6978,8651,044,659-6
Revenue by GeographyInternational119,567112,2117241,907216,61012
Revenue by GeographyTotal Revenue606,927631,900-41,220,7721,261,269-3

Income Statement

(In thousands, unaudited) (in thousands)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025Outlook in millions (8) – Second Quarter – 2026Outlook in millions (8) – Full Year – 2026
Net loss-38,908-32,660-102,745-125,672$(55) - (36)$(181) - (136)
Add:Provision for income taxes997-7,7633,992-26,018
Add:Other expense (income), net2,191-8,3712,387-10,806
Add:Interest expense5,1094,47310,47710,238
Add:Interest income-6,481-10,064-12,971-22,738
Add:Depreciation of property and equipment2,4684,3384,9297,902
Add:Amortization of intangible assets88,44288,664178,268172,968
Add:Restructuring costs9045,69212,87910,039
Add:Acquisition, integration, and transformation costs1,6902,6582,7544,846
Add:Goodwill impairment59,138
Add:Stock-based compensation9,30122,34423,91247,507
Add:Total Adjustments104,621101,971226,627253,07698 - 129407 - 484
Add:Consolidated Adjusted EBITDA65,71369,311123,882127,404$62 - 74$271 - 303
Segment Adjusted EBITDAIntegrated Care65,24257,450121,519107,829
Segment Adjusted EBITDABetterHelp47111,8612,36319,575
Segment Adjusted EBITDAConsolidated Adjusted EBITDA65,71369,311123,882127,404

Balance Sheet

(In thousands, except share and per share data, unaudited)

June 30, 2026December 31, 2025
Current assets:Cash and cash equivalents774,348781,084
Current assets:Accounts receivable, net of allowance for doubtful accounts of $3,628 and $4,033 at June 30, 2026 and December 31, 2025, respectively221,015192,826
Current assets:Inventories28,82338,203
Current assets:Prepaid expenses and other current assets124,175107,016
Current assets:Total current assets1,148,3611,119,129
Current assets:Property and equipment, net24,69026,972
Current assets:Goodwill283,190283,190
Current assets:Intangible assets, net1,175,6691,297,087
Current assets:Operating lease—right-of-use assets22,71826,119
Current assets:Other assets103,997105,803
Current assets:Total assets2,758,6252,858,300
Current liabilities:Accounts payable37,49647,967
Current liabilities:Accrued expenses and other current liabilities226,550198,208
Current liabilities:Accrued compensation60,17296,258
Current liabilities:Deferred revenue, current60,81262,305
Current liabilities:Convertible senior notes, net—current996,700
Current liabilities:Total current liabilities1,381,730404,738
Current liabilities:Operating lease liabilities, net of current portion29,53734,204
Current liabilities:Deferred revenue, net of current portion9,6699,139
Current liabilities:Deferred taxes, net26,88128,945
Current liabilities:Convertible senior notes, net—non-current994,925
Current liabilities:Other liabilities700643
Current liabilities:Total liabilities1,448,5171,472,594
Stockholders’ equity:Common stock, $0.001 par value; 300,000,000 shares authorized; 181,649,591 shares and 178,315,400 shares issued and outstanding as of June 30, 2026 and December 31, 2025 respectively182178
Stockholders’ equity:Additional paid-in capital17,876,82717,850,478
Stockholders’ equity:Accumulated deficit-16,532,967-16,430,222
Stockholders’ equity:Accumulated other comprehensive loss-33,934-34,728
Stockholders’ equity:Total stockholders’ equity1,310,1081,385,706
Stockholders’ equity:Total liabilities and stockholders’ equity2,758,6252,858,300

Cash Flow

Six Months Ended June 30, — (In thousands, unaudited) (in thousands)

Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Cash flows from operating activities:Net loss-102,745-125,672
Adjustments to reconcile net loss to net cash flows from operating activities:Goodwill impairment59,138
Adjustments to reconcile net loss to net cash flows from operating activities:Amortization of intangible assets178,268172,968
Adjustments to reconcile net loss to net cash flows from operating activities:Stock-based compensation23,91247,507
Adjustments to reconcile net loss to net cash flows from operating activities:Depreciation of property and equipment4,9297,902
Adjustments to reconcile net loss to net cash flows from operating activities:Amortization of right-of-use assets3,3944,190
Adjustments to reconcile net loss to net cash flows from operating activities:Provision for allowances for doubtful accounts807377
Adjustments to reconcile net loss to net cash flows from operating activities:Deferred income taxes-1,673-34,072

Cash Flow

Three Months Ended — (In thousands, unaudited) (in millions)

Three Months Ended – June 30, – 2026Three Months Ended – June 30, – 2025Six Months Ended – June 30, – 2026Six Months Ended – June 30, – 2025Outlook (9) – Full Year
Net cash provided by operating activities64,66291,43274,178107,351$260 - 290
Capital expenditures-928-1,268-2,588-3,994
Capitalized software development costs-27,990-28,965-62,152-57,824
Capex-28,918-30,233-64,740-61,818(130) - (120)
Free Cash Flow35,74461,1999,43845,533$130 - 170
Full release

(1) decreased 5% to $65.7 million, compared to $69.3 million for Second Quarter 2025. The Integrated Care segment adjusted EBITDA increase of $7.8 million was offset by a $11.4 million decrease of the BetterHelp segment adjusted EBITDA in Second Quarter 2026.

Six Months Ended June 30, 2026

Revenue decreased 3% to $1,220.8 million from $1,261.3 million in the first six months of 2025. Access fees revenue decreased 9% to $958.9 million while other revenue increased 24% to $261.9 million. U.S. revenue decreased 6% to $978.9 million while International revenue increased 12% to $241.9 million.

Integrated Care segment revenue increased 1% to $789.8 million in the first six months of 2026 while BetterHelp segment revenue decreased 10% to $431.0 million.

Net loss totaled $102.7 million, or $0.57 per share, for the first six months of 2026, compared to $125.7 million, or $0.72 per share, for the first six months of 2025. Results for the first six months of 2026 included amortization of intangibles of $178.3 million, or $0.99 per share pre-tax, and stock-based compensation expense of $23.9 million, or $0.13 per share pre-tax. Net loss for the first six months of 2026 also included restructuring costs of $12.9 million, or $0.07 per share pre-tax, primarily related to severance costs.... (truncated)it study and acquisition related tax benefits of $11.1 million, or $0.06 per share.

The non-cash goodwill impairment charge recorded in the first six months of 2025 was the result of the fair value of the Integrated Care segment being less than its carrying value at the time of the acquisition of Catapult Health, LLC.

Adjusted EBITDA

(1) decreased 3% to $123.9 million, compared to $127.4 million for the first six months of 2025. The Integrated Care segment adjusted EBITDA increase of $13.7 million was offset by a $17.2 million decrease of the BetterHelp segment adjusted EBITDA in the first six months of 2026.

Capex and Cash Flow

Cash flow from operations was $64.7 million in Second Quarter 2026, compared to $91.4 million in Second Quarter 2025, and was $74.2 million in the first six months of 2026, compared to $107.4 million in the first six months of 2025. Capital expenditures and capitalized software development costs (together, “Capex”)² were $28.9 million in Second Quarter 2026, compared to $30.2 million in Second Quarter 2025, and were $64.7 million in the first six months of 2026, compared to $61.8 million in the first six months of 2025. Free cash flow was $35.7 million in Second Quarter 2026, compared to $61.2 million in Second Quarter 2025, and was $9.4 million in the first six months of 2026, compared to $45.5 million in the first six months of 2025.

Financial Outlook

The outlook provided below is based on current market conditions and expectations and what we know today.

See note (2) in the Notes section that follows.³

Earnings Conference Call

The Second Quarter 2026 earnings conference call and webcast will be held Wednesday, July 29, 2026 at 5:00 p.m. E.T. The conference call can be accessed by dialing 833-461-5787 for U.S. participants and using the conference ID # 478 236 923. For international participants, please visit the following link for global dial-in numbers, using the same conference ID # 478 236 923: https://help.events.q4inc.com/eahc/international-dial-in-numbers. A live audio webcast will also be available online at http://ir.teladoc.com/news-and-events/events-and-presentations/. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Teladoc Health

Teladoc Health is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at www.teladochealth.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements include, among others, the information under the caption “Financial Outlook” and statements we make regarding future financial or operating results, future numbers of members, BetterHelp paying users or clients, litigation outcomes, regulatory developments, market developments, new products and growth strategies, initiatives to improve our efficiency and competitiveness, and the effects of any of the foregoing on our future results of operations or financial condition.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that have in the past and/or may in the future cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) changes in laws and regulations applicable to our business model; (ii) changes in market conditions and receptivity to our services and offerings, including our ability to effectively compete; (iii) results of litigation or regulatory actions; (iv) the loss of one or more key clients or the loss of a significant number of members or BetterHelp paying users; (v) a decrease in revenue from users who pay directly out-of-pocket without offsetting growth in insurance-covered services in our BetterHelp segment; (vi) changes in valuations or useful lives of our assets; (vii) changes to our abilities to recruit and retain qualified providers into our network; (viii) the impact of and risk related to impairment losses with respect to goodwill or other assets; (ix) the success of our initiatives to improve our efficiency and competitiveness; (x) imposed and threatened tariffs by the United States and its trading partners, and any resulting disruptions or inefficiencies in our supply chain; (xi) the rate and magnitude of declines in BetterHelp cash-pay users and revenue; (xii) the extent to which insurance availability changes users’ payment choices; (xiii) available provider capacity including on a state and payer specific basis; (xiv) the timing, cost and effectiveness of provider recruitment, credentialing, enrollment, activation, compensation and retention; (xv) the performance of insurance-specific eligibility, matching, booking, scheduling, utilization, session-duration, claims and collection workflows; (xvi) the effectiveness and revenue consequences of changes in advertising and marketing spending; (xvii) the effects of BetterHelp’s reduced near term emphasis and investment outside the United States; (xviii) the cost, timing and effectiveness of platform and provider-capacity investments; (xix) the margin effects of the insurance mix; and (xx) potential impairment of BetterHelp goodwill. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our SEC reports, including, but not limited to, our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as filed with the SEC.⁴

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise, except as required by law.⁵

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Teladoc Health earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.